{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T16:57:29Z","timestamp":1770483449905,"version":"3.49.0"},"reference-count":90,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2010,8,1]],"date-time":"2010-08-01T00:00:00Z","timestamp":1280620800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Best Practice &amp; Research Clinical Rheumatology"],"published-print":{"date-parts":[[2010,8]]},"DOI":"10.1016\/j.berh.2009.11.009","type":"journal-article","created":{"date-parts":[[2010,8,22]],"date-time":"2010-08-22T08:38:42Z","timestamp":1282466322000},"page":"443-455","source":"Crossref","is-referenced-by-count":13,"title":["Optimising the strategy of care in early rheumatoid arthritis"],"prefix":"10.1016","volume":"24","author":[{"given":"James","family":"Dale","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Duncan","family":"Porter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.berh.2009.11.009_bib1","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1002\/1529-0131(199908)42:8<1706::AID-ANR20>3.0.CO;2-Z","article-title":"The relationship between synovitis and bone changes in early untreated arthritis","volume":"42","author":"McGonagle","year":"1999","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.berh.2009.11.009_bib2","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1093\/rheumatology\/37.10.1084","article-title":"Diagnosis and course of early-onset arthritis: results of a special early arthritis clinic compared to routine patient care","volume":"37","author":"Van der Horst-Bruinsma","year":"1998","journal-title":"Br J Rheumatol"},{"key":"10.1016\/j.berh.2009.11.009_bib3","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1002\/art.23721","article-title":"American College of Rheumatology 2008 recommendations for the use of nonbiologic and biologic disease modifying antirheumatic drugs in rheumatoid arthritis","volume":"59","author":"Saag","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.berh.2009.11.009_bib4","series-title":"Rheumatoid arthritis: national clinical guideline for management and treatment in adults","author":"National Collaborating Centre for Chronic Conditions","year":"2009"},{"key":"10.1016\/j.berh.2009.11.009_bib5","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1093\/rheumatology\/37.12.1324","article-title":"Clinical course and remission rate in patients with early rheumatoid arthritis: relationship to outcome after 5 years","volume":"37","author":"Eberhardt","year":"1998","journal-title":"Br J Rheumatol"},{"key":"10.1016\/j.berh.2009.11.009_bib6","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1002\/art.10135","article-title":"Delay to institution of therapy and induction of remission using single drug or combination disease modifying antirheumatic drug therapy in early rheumatoid arthritis","volume":"46","author":"Mottonen","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.berh.2009.11.009_bib7","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1002\/art.22353","article-title":"Long-term impact of early treatment on radiographic progression in rheumatoid arthritis: a meta-analysis","volume":"55","author":"Finckh","year":"2006","journal-title":"Arthritis Rheum"},{"issue":"Suppl. 31","key":"10.1016\/j.berh.2009.11.009_bib8","first-page":"S20","article-title":"Joint damage and disability in rheumatoid arthritis: an updated systematic review","volume":"21","author":"Scott","year":"2003","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.berh.2009.11.009_bib9","first-page":"1072","article-title":"Long-term mortality outcome in patients with rheumatoid arthritis: early presenters continue to do well","volume":"25","author":"Symmons","year":"1998","journal-title":"J Rheumatol"},{"key":"10.1016\/j.berh.2009.11.009_bib10","first-page":"2208","article-title":"Patients with early rheumatoid arthritis benefit from early 2nd line therapy: 5 year follow-up of a prospective, double blind, placebo controlled study","volume":"22","author":"Egsmose","year":"1995","journal-title":"J Rheumatol"},{"key":"10.1016\/j.berh.2009.11.009_bib11","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1002\/1529-0131(200001)43:1<22::AID-ANR4>3.0.CO;2-9","article-title":"Factors predicting response to treatment in rheumatoid arthritis. The importance of disease duration","volume":"43","author":"Anderson","year":"2000","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.berh.2009.11.009_bib12","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1136\/ard.57.2.88","article-title":"Improved functional outcome in patients with early rheumatoid arthritis treated with intramuscular gold: results of a five year prospective study","volume":"57","author":"Munro","year":"1998","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.berh.2009.11.009_bib13","doi-asserted-by":"crossref","first-page":"2184","DOI":"10.1002\/1529-0131(199910)42:10<2184::AID-ANR20>3.0.CO;2-2","article-title":"Persistence of mild, early inflammatory arthritis. The importance of disease duration, rheumatoid factor and the shared epitope","volume":"42","author":"Green","year":"1999","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.berh.2009.11.009_bib14","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1002\/art.24447","article-title":"The good initial response to therapy with a combination of traditional disease modifying antirheumatic drugs is sustained over time","volume":"60","author":"Rantalaiho","year":"2009","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.berh.2009.11.009_bib15","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1056\/NEJM199309303291401","article-title":"The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus","volume":"329","author":"The Diabetes Control and Complications Trial Research Group","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1016\/j.berh.2009.11.009_bib16","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1002\/art.10747","article-title":"Elucidation of the relationship between synovitis and bone damage. A randomized magnetic resonance imaging study of individual joints in patients with early rheumatoid arthritis","volume":"48","author":"Conaghan","year":"2003","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.berh.2009.11.009_bib17","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1136\/ard.2003.015172","article-title":"Relations between inflammation and joint destruction in early rheumatoid arthritis: a mathematical description","volume":"63","author":"Wick","year":"2004","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.berh.2009.11.009_bib18","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S0140-6736(04)16676-2","article-title":"Effect of a treatment strategy of tight control for rheumatoid arthritis (the TICORA study): a single-blind randomized controlled trial","volume":"364","author":"Grigor","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.berh.2009.11.009_bib19","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1136\/ard.2007.071092","article-title":"Intensive treatment with methotrexate in early rheumatoid arthritis: aiming for remission. Computer Assisted Management in Early Rheumatoid Arthritis (CAMERA, an open label strategy trial)","volume":"66","author":"Verstappen","year":"2007","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.berh.2009.11.009_bib20","doi-asserted-by":"crossref","first-page":"3381","DOI":"10.1002\/art.21405","article-title":"Clinical and radiographic outcomes of four different treatment strategies in patients with early rheumatoid arthritis (the BeSt Study)","volume":"52","author":"Goekoop-Ruiterman","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.berh.2009.11.009_bib21","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1016\/S0140-6736(98)08513-4","article-title":"Comparison of combination therapy with single-drug therapy in early rheumatoid arthritis: a randomized trial","volume":"353","author":"Mottonen","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.berh.2009.11.009_bib22","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1093\/rheumatology\/kei031","article-title":"A meta-analysis of the efficacy and toxicity of combining disease-modifying anti-rheumatic drugs in rheumatoid arthritis based on patient withdrawal","volume":"44","author":"Choy","year":"2005","journal-title":"Rheumatology"},{"key":"10.1016\/j.berh.2009.11.009_bib23","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S0140-6736(97)01300-7","article-title":"Randomised comparison of combined step-down prednisolone, methotrexate and sulphasalazine with sulphasalazine alone in early rheumatoid arthritis","volume":"350","author":"Boers","year":"1997","journal-title":"Lancet"},{"issue":"Suppl. 1","key":"10.1016\/j.berh.2009.11.009_bib24","first-page":"i56","article-title":"Early rheumatoid arthritis network (ERAN) audit of ARMA standards of access to rheumatology services for patients with early RA","volume":"45","author":"Williams","year":"2006","journal-title":"Rheumatology"},{"key":"10.1016\/j.berh.2009.11.009_bib25","doi-asserted-by":"crossref","first-page":"124","DOI":"10.7326\/0003-4819-148-2-200801150-00192","article-title":"Systematic effectiveness and harms of disease-modifying medications for rheumatoid arthritis","volume":"148","author":"Donahue","year":"2008","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.berh.2009.11.009_bib26","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1016\/S0140-6736(02)08213-2","article-title":"Methotrexate and mortality in patients with rheumatoid arthritis: a prospective study","volume":"359","author":"Choi","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.berh.2009.11.009_bib27","first-page":"645","article-title":"Combination therapy in rheumatoid arthritis \u2013 no benefit from of addition of hydroxychloroquine to patients with a suboptimal response to intramuscular gold","volume":"20","author":"Porter","year":"1993","journal-title":"J Rheumatol"},{"key":"10.1016\/j.berh.2009.11.009_bib28","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1002\/art.10228","article-title":"Treatment of rheumatoid arthritis with methotrexate and hydroxychloroquine, methotrexate and sulphasalazine or a combination of the three medications. Results of a two year, randomized, double-blind, placebo-controlled trial","volume":"46","author":"O'Dell","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.berh.2009.11.009_bib29","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1056\/NEJM199507203330301","article-title":"Combination therapy with cyclosporine and methotrexate in severe rheumatoid arthritis","volume":"333","author":"Tugwell","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1016\/j.berh.2009.11.009_bib30","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1002\/art.1780401018","article-title":"Combination treatment of severe rheumatoid arthritis with cyclosporine and methotrexate for forty-eight weeks. An open label extension study","volume":"40","author":"Stein","year":"1997","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.berh.2009.11.009_bib31","doi-asserted-by":"crossref","first-page":"726","DOI":"10.7326\/0003-4819-137-9-200211050-00007","article-title":"Concomitant leflunomide therapy in patients with active rheumatoid arthritis despite stable dose methotrexate","volume":"137","author":"Kremer","year":"2002","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.berh.2009.11.009_bib32","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1002\/art.21018","article-title":"A 48 week, randomized, double-blind, double-observer, placebo-controlled multicenter trial of combination methotrexate and intramuscular gold therapy in rheumatoid arthritis. Results of the METGO Study","volume":"52","author":"Lehman","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.berh.2009.11.009_bib33","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1093\/rheumatology\/36.10.1082","article-title":"Combination of sulphasalazine and methotrexate versus the single components in early rheumatoid arthritis: a randomized, controlled, double-blind, 52 week clinical trial","volume":"36","author":"Haagsma","year":"1997","journal-title":"Br J Rheumatol"},{"key":"10.1016\/j.berh.2009.11.009_bib34","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1136\/ard.58.4.220","article-title":"Combination therapy in early rheumatoid arthritis: a randomised, controlled, double blind 52 week clinical trial of sulphasalazine and methotrexate compared with the single components","volume":"58","author":"Dougados","year":"1999","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.berh.2009.11.009_bib35","doi-asserted-by":"crossref","first-page":"2072","DOI":"10.1002\/art.20351","article-title":"Retardation of joint damage in patients with early rheumatoid arthritis by initial aggressive treatment with disease-modifying antirheumatic drugs. Five year experience from the FIN-RACo Study","volume":"50","author":"Korpela","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.berh.2009.11.009_bib36","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1002\/art.11436","article-title":"Impact of initial aggressive drug treatment with a combination of work disease-modifying antirheumatic drugs on the development of work disability in early rheumatoid arthritis. A five-year randomized follow-up trial","volume":"50","author":"Puolakka","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.berh.2009.11.009_bib37","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1002\/art.24447","article-title":"The good initial response to therapy with a combination of traditional disease-modifying antirheumatic drugs is sustained over time. The eleven-year results of the Finnish Rheumatoid Arthritis Combination Therapy Trial","volume":"60","author":"Rantalaiho","year":"2009","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.berh.2009.11.009_bib38","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1002\/art.21796","volume":"54","author":"Hetland","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.berh.2009.11.009_bib39","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1136\/ard.2007.076307","article-title":"Aggressive combination therapy with intra-articular glucocorticoid injections and conventional disease-modifying anti-rheumatic drugs in early rheumatoid arthritis: second year clinical and radiographic results from the CIMESTRA study","volume":"67","author":"Hetland","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.berh.2009.11.009_bib40","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1093\/rheumatology\/keg394","article-title":"Radiographic progression in early rheumatoid arthritis: a 12 month randomized controlled study comparing the combination of cyclosporine and methotrexate with methotrexate alone","volume":"42","author":"Marchesoni","year":"2003","journal-title":"Rheumatology"},{"key":"10.1016\/j.berh.2009.11.009_bib41","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1002\/art.10083","article-title":"COBRA Combination therapy in patients with early rheumatoid arthritis. Long-term structural benefits of a brief intervention","volume":"46","author":"Landewe","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.berh.2009.11.009_bib42","doi-asserted-by":"crossref","first-page":"406","DOI":"10.7326\/0003-4819-146-6-200703200-00005","article-title":"Comparison of treatment strategies in early rheumatoid arthritis. A randomized trial","volume":"146","author":"Goekoop-Ruiterman","year":"2007","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.berh.2009.11.009_bib43","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1002\/art.23449","article-title":"Triple therapy in early, active rheumatoid arthritis. A randomized, single blind, controlled trial comparing step-up and parallel treatment strategies","volume":"58","author":"Saunders","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.berh.2009.11.009_bib44","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1093\/rheumatology\/kel215a","article-title":"British Society for Rheumatology and British Health Professionals in Rheumatology Guideline for the management of rheumatoid arthritis (the first 2 years)","volume":"45","author":"Luqmani","year":"2007","journal-title":"Rheumatology"},{"key":"10.1016\/j.berh.2009.11.009_bib45","doi-asserted-by":"crossref","first-page":"3432","DOI":"10.1002\/art.20568","article-title":"Combination of infliximab and methotrexate therapy for early rheumatoid arthritis: a randomized, controlled trial","volume":"50","author":"St Clair","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.berh.2009.11.009_bib46","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1002\/art.21519","volume":"54","author":"Breedveld","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.berh.2009.11.009_bib47","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/S0140-6736(08)61000-4","article-title":"Comparison of methotrexate monotherapy with a combination of methotrexare and etanercept in active, early, moderate to severe rheumatoid arthritis (COMET): a randomised, double-blind, parallel treatment trial","volume":"372","author":"Emery","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.berh.2009.11.009_bib48","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1093\/rheumatology\/23.2.92","article-title":"Cause of death in rheumatoid arthritis","volume":"23","author":"Prior","year":"1984","journal-title":"Br J Rheumatol"},{"key":"10.1016\/j.berh.2009.11.009_bib49","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1002\/art.1780370408","article-title":"The mortality of rheumatoid arthritis","volume":"37","author":"Wolfe","year":"1994","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.berh.2009.11.009_bib50","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1186\/ar2177","article-title":"Biological therapy in early arthritis \u2013 overtreatment or the way to go?","volume":"9","author":"Ikeda","year":"2007","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.berh.2009.11.009_bib51","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1001\/jama.295.19.2275","article-title":"Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies: systematic review and meta-analysis of rare harmful effects in randomized controlled trials","volume":"295","author":"Bongatz","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.berh.2009.11.009_bib52","doi-asserted-by":"crossref","first-page":"2368","DOI":"10.1002\/art.21978","article-title":"Rates of serious infection, including site-specific and bacterial intracellular infection, in rheumatoid arthritis patients receiving anti-tumour necrosis factor therapy","volume":"54","author":"Dixon","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.berh.2009.11.009_bib53","doi-asserted-by":"crossref","first-page":"2896","DOI":"10.1002\/art.22808","article-title":"Serious infection following anti-tumour necrosis factor alpha therapy in patients with rheumatoid arthritis. Lessons from interpreting data from observational studies","volume":"56","author":"Dixon","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.berh.2009.11.009_bib54","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1086\/383317","article-title":"Granulomatous infectious diseases associated with tumour necrosis factor antagonists","volume":"38","author":"Wallis","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.berh.2009.11.009_bib55","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1002\/art.11137","article-title":"Treatment of rheumatoid arthritis with tumour necrosis factor inhibitors may predispose to significant increases in tuberculosis risk: a multicenter active-surveillance report","volume":"48","author":"Gomez-Reino","year":"2003","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.berh.2009.11.009_bib56","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1136\/ard.2004.030528","article-title":"Tumour necrosis factor blockers do not increase overall tumour risk in patients with rheumatoid arthritis, but may be associated with an increased risk of lymphomas","volume":"64","author":"Geborek","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.berh.2009.11.009_bib57","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1136\/ard.2004.033993","article-title":"Risks of solid cancers in patients with rheumatoid arthritis and after treatment with tumour necrosis factor antagonists","volume":"64","author":"Askling","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.berh.2009.11.009_bib58","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1136\/ard.2004.033241","article-title":"Haematopoietic malignancies in rheumatoid arthritis: lymphoma risk and characteristics after exposure to tumour necrosis factor antagonists","volume":"64","author":"Askling","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.berh.2009.11.009_bib59","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1002\/art.20712","volume":"52","author":"Quinn","year":"2005","journal-title":"Arthritis Rheum"},{"issue":"Suppl.","key":"10.1016\/j.berh.2009.11.009_bib60","first-page":"S918","article-title":"Remission induction with etanercept and methotrexate in very early rheumatoid arthritis with sustained remission after etanercept withdrawal","volume":"58","author":"Sheehy","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.berh.2009.11.009_bib61","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1002\/art.22718","article-title":"Infliximab and methotrexate as induction therapy in patients with early rheumatoid arthritis","volume":"56","author":"Van der Bijl","year":"2007","journal-title":"Arthritis Rheum"},{"issue":"Suppl. 3","key":"10.1016\/j.berh.2009.11.009_bib62","first-page":"581","article-title":"Rituximab improved physical function and quality of life in patients with early rheumatoid arthritis; results from a randomized active comparator placebo-controlled trial of rituximab in combination with methotrexate compared to methotrexate alone","volume":"68","author":"Rigby","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.berh.2009.11.009_bib63","doi-asserted-by":"crossref","DOI":"10.1136\/ard.2008.101121","article-title":"Clinical efficacy and safety of abatacept in methotrexate-na\u00efve patients with early rheumatoid arthritis and poor prognostic factors","author":"Westhovens","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.berh.2009.11.009_bib64","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1002\/art.20018","article-title":"Specific autoantibodies precede the symptoms of rheumatoid arthritis. A study of serial measurements in blood donors","volume":"50","author":"Nielen","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.berh.2009.11.009_bib65","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.berh.2008.11.004","article-title":"The preclinical stages of RA: lessons from human studies and animal models","volume":"23","author":"El-Gabalawy","year":"2009","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"10.1016\/j.berh.2009.11.009_bib66","doi-asserted-by":"crossref","first-page":"706","DOI":"10.3899\/jrheum.080895","article-title":"Continuous measures of anti-cyclic citrullinated peptide antibodies in predicting future rheumatoid arthritis","volume":"36","author":"Chibnik","year":"2009","journal-title":"J Rheumatol"},{"key":"10.1016\/j.berh.2009.11.009_bib67","doi-asserted-by":"crossref","first-page":"3000","DOI":"10.1002\/art.23763","article-title":"Marked differences in fine specificity and isotype usage of the anti-citrullinated protein antibody in health and disease","volume":"58","author":"Ioan-Facsinay","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.berh.2009.11.009_bib68","doi-asserted-by":"crossref","first-page":"2232","DOI":"10.1002\/art.24716","volume":"60","author":"Van der Linden","year":"2009","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.berh.2009.11.009_bib69","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1136\/ard.2005.038471","article-title":"Comparison of long-term outcome of patients with rheumatoid arthritis presenting with undifferentiated arthritis or with rheumatoid arthritis: an observational cohort study","volume":"65","author":"Van Aken","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.berh.2009.11.009_bib70","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.1002\/art.23681","article-title":"Validation of a prediction rule for disease outcome in patients with recent onset undifferentiated arthritis. Moving towards individualized treatment decisions","volume":"58","author":"Van der Helm-van Mil","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.berh.2009.11.009_bib71","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.semarthrit.2007.10.012","article-title":"Usefulness of magnetic resonance imaging of the hand versus anti-cyclic citrullinated peptide antibody testing to confirm the diagnosis of clinically suspected early rheumatoid arthritis in the absence of rheumatoid factor and radiographic erosions","volume":"38","author":"Narvaez","year":"2008","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.berh.2009.11.009_bib72","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1093\/rheumatology\/kep136","article-title":"Tenosynovitis of the flexor tendons of the hand detected by MRI: an early indicator of rheumatoid arthritis","volume":"48","author":"Eshed","year":"2009","journal-title":"Rheumatology"},{"key":"10.1016\/j.berh.2009.11.009_bib73","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1002\/art.22619","article-title":"Evaluation of the preliminary definitions of minimal disease activity and remission in an early seropositive rheumatoid arthritis cohort","volume":"57","author":"Khanna","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.berh.2009.11.009_bib74","doi-asserted-by":"crossref","first-page":"3761","DOI":"10.1002\/art.22190","article-title":"Presence of significant synovitis in rheumatoid arthritis patients with disease-modifying antirheumatic drug-induced clinical remission. Evidence from an imaging study may explain structural progression","volume":"54","author":"Brown","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.berh.2009.11.009_bib75","doi-asserted-by":"crossref","first-page":"2958","DOI":"10.1002\/art.23945","article-title":"An explanation for the apparent dissociation between clinical remission and continued structural deterioration in rheumatoid arthritis","volume":"58","author":"Brown","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.berh.2009.11.009_bib76","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1002\/1529-0131(200109)44:9<2018::AID-ART350>3.0.CO;2-C","article-title":"Power Doppler ultrasonography for assessment of synovitis in the metacarpophalangeal joints of patients with rheumatoid arthritis: a comparison with dynamic magnetic resonance imaging","volume":"44","author":"Szkudlarek","year":"2001","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.berh.2009.11.009_bib77","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1002\/1529-0131(200102)44:2<331::AID-ANR50>3.0.CO;2-0","article-title":"Correlation of power Doppler sonography with vascularity of the synovial tissue of the knee joint in patients with osteoarthritis and rheumatoid arthritis","volume":"44","author":"Walther","year":"2001","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.berh.2009.11.009_bib78","doi-asserted-by":"crossref","first-page":"2248","DOI":"10.1002\/art.23682","article-title":"Power Doppler ultrasonographic monitoring of response to anti-tumour necrosis factor therapy in patients with rheumatoid arthritis","volume":"58","author":"Naredo","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.berh.2009.11.009_bib79","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1002\/art.22461","article-title":"Longitudinal power Doppler ultrasonographic assessment of joint inflammatory activity in early rheumatoid arthritis: predictive value in disease activity and radiologic progression","volume":"57","author":"Naredo","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.berh.2009.11.009_bib80","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1002\/art.20939","article-title":"A novel ultrasonographic synovitis scoring system suitable for analysing finger joint inflammation in rheumatoid arthritis","volume":"52","author":"Sheel","year":"2005","journal-title":"Arthritis Rheum"},{"issue":"Suppl.","key":"10.1016\/j.berh.2009.11.009_bib81","first-page":"S464","article-title":"Evaluation of a novel 7 joint sonographic score (US7) in daily rheumatologic practice \u2013 6 months results of multi center project in Germany","volume":"58","author":"Ohrndorf","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.berh.2009.11.009_bib82","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1002\/art.23529","article-title":"Validity, reproducibility and responsiveness of a twelve-joint simplified power Doppler ultrasonographic assessment of joint inflammation in rheumatoid arthritis","volume":"59","author":"Naredo","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.berh.2009.11.009_bib83","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1093\/rheumatology\/kem257","article-title":"Clinical identification and treatment of a rapidly progressing disease state in patients with rheumatoid arthritis","volume":"47","author":"Emery","year":"2008","journal-title":"Rheumatology"},{"key":"10.1016\/j.berh.2009.11.009_bib84","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1002\/1529-0131(200007)43:7<1473::AID-ANR9>3.0.CO;2-N","article-title":"Relationship between time-integrated C-reactive protein levels and radiologic progression in patients with rheumatoid arthritis","volume":"43","author":"Plant","year":"2000","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.berh.2009.11.009_bib85","first-page":"1002","article-title":"Antibodies against mutated citrullinated vimentin are a better predictor of disease activity at 24 months in early rheumatoid arthritis than antibodies against cyclic citrullinate peptides","volume":"35","author":"Innala","year":"2008","journal-title":"J Rheumatol"},{"key":"10.1016\/j.berh.2009.11.009_bib86","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1002\/art.23667","article-title":"Potential novel biomarkers of disease activity in rheumatoid arthritis patients. CXCL13, CCL23, transforming growth factor \u03b1, tumour necrosis factor receptor superfamily member 9 and macrophage colony-stimulating factor","volume":"58","author":"Rioja","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.berh.2009.11.009_bib87","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1136\/ard.2008.096057","article-title":"Effects of infliximab therapy on biological markers of synovium activity and cartilage breakdown in patients with rheumatoid arthritis","volume":"68","author":"Marotte","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.berh.2009.11.009_bib88","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1136\/ard.2008.090712","article-title":"Tight control and intensified COBRA combination treatment in early rheumatoid arthritis: 90% remission in a pilot study","volume":"67","author":"Van Tuyl","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.berh.2009.11.009_bib89","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1002\/art.20221","article-title":"Combination therapy with etanercept and anakinra in the treatment of patients with rheumatoid arthritis who have been treated unsuccessfully with methotrexate","volume":"50","author":"Genovese","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.berh.2009.11.009_bib90","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1002\/art.23417","article-title":"Denosumab treatment effects on structural damage, bone mineral density, and bone turnover in rheumatoid arthritis. A twelve-month, multicenter, randomized, double-blind, placebo controlled, phase II clinical trial","volume":"58","author":"Cohen","year":"2008","journal-title":"Arthritis Rheum"}],"container-title":["Best Practice &amp; Research Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521694209001454?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521694209001454?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T05:47:02Z","timestamp":1559454422000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521694209001454"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,8]]},"references-count":90,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2010,8]]}},"alternative-id":["S1521694209001454"],"URL":"https:\/\/doi.org\/10.1016\/j.berh.2009.11.009","relation":{},"ISSN":["1521-6942"],"issn-type":[{"value":"1521-6942","type":"print"}],"subject":[],"published":{"date-parts":[[2010,8]]}}}